TCM
FLNA

Tradewinds Capital Management’s Filana Therapeutics FLNA Stock Holding History

Tradewinds Capital Management’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-225
Closed -$6.62K – 708
2024
Q3 		$6.62K Hold
225
– – ﹤0.01% 386
2024
Q2 		$2.78K Hold
225
– – ﹤0.01% 423
2024
Q1 		$4.57K Hold
225
– – ﹤0.01% 365
2023
Q4 		$5.07K Hold
225
– – ﹤0.01% 285
2023
Q3 		$3.74K Buy
+225
New +$4.46K ﹤0.01% 304
2022
Q2 		– Sell
-225
Closed -$8K – 719
2022
Q1 		$8K Hold
225
– – ﹤0.01% 510
2021
Q4 		$10K Buy
+225
New +$11.8K ﹤0.01% 495

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

Tradewinds Capital Management's FLNA Position: Q4 2024 in Review

Tradewinds Capital Management sold out of Filana Therapeutics (FLNA) in Q4 2024, closing a stake of 225 shares — an estimated $6.62K sold.

Tradewinds Capital Management first reported a position in FLNA in Q4 2021 and held it in 7 quarters. The position peaked at $10K in Q4 2021. 137 funds tracked by Wall St. Rank hold FLNA as of Q4 2024.

  • Tradewinds Capital Management reported no remaining Filana Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Tradewinds Capital Management sold 225 Filana Therapeutics shares in Q4 2024, an estimated $6.62K.
  • Tradewinds Capital Management first reported a position in Filana Therapeutics in Q4 2021 and held it in 7 quarters.
  • Tradewinds Capital Management's Filana Therapeutics position peaked at $10K in Q4 2021.
  • 137 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2024.

Based on Tradewinds Capital Management's 13F filing for Q4 2024, filed 4 Feb 2025.